<DOC>
	<DOCNO>NCT01452828</DOCNO>
	<brief_summary>The purpose study assess single dose pharmacokinetics ( PK ) safety TR701 FA subject advance renal impairment .</brief_summary>
	<brief_title>A Pharmacokinetics Safety Study Subjects With Renal Impairment</brief_title>
	<detailed_description>To assess pharmacokinetics ( PK ) evaluate safety intravenous ( IV ) infusion TR-701 free acid ( FA ) subject advanced renal impairment compare match control subject normal renal function</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Torezolid</mesh_term>
	<mesh_term>Torezolid phosphate</mesh_term>
	<criteria>BMI 18.0 40.0 kg/m2 inclusive Male female subject 18 75 year age Stable dosage medication 30 day dialysis patient , receive chronic stable maintenance hemodialysis least 3 month Functioning transplant solid organ High tyramine diet Significant , unstable , lifethreatening condition organ system condition disease , kidney disease renal subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Renal Impairment</keyword>
</DOC>